Please use this identifier to cite or link to this item: https://hdl.handle.net/1959.11/31891
Full metadata record
DC FieldValueLanguage
dc.contributor.authorClark, Hannahen
dc.contributor.authorRana, Rezwanulen
dc.contributor.authorGow, Jeffen
dc.contributor.authorPearson, Melissaen
dc.contributor.authorvan der Touw, Tomen
dc.contributor.authorSmart, Neilen
dc.date.accessioned2021-11-11T04:03:21Z-
dc.date.available2021-11-11T04:03:21Z-
dc.date.issued2022-03-
dc.identifier.citationHeart Failure Reviews, 27(2), p. 559-572en
dc.identifier.issn1573-7322en
dc.identifier.issn1382-4147en
dc.identifier.urihttps://hdl.handle.net/1959.11/31891-
dc.description.abstract<p>Heart failure with preserved ejection fraction (HFpEF) is problematic to treat, with guidelines for HFpEF management concentrated on treating prevalent comorbidities. The aim of this study is to conduct a systematic review of the economic burden of hospitalisation for HFpEF. We conducted a systematic literature search from 2001, when HFpEF was first identified as an isolated diagnosis, up to July 1, 2020. Databases searched include PubMed, Medline, EMBASE, EBSCO, National Health Service Economic Evaluation and the National Bureau of Economic Research. The primary outcome measure was hospitalisation costs related to HFpEF. A comprehensive search of the literature produced a total of 243 possible studies. A total of nine studies, six from the U.S., met inclusion criteria and were included in this review. All results are presented in United States Dollars (US$) for the financial year 2019. Costs of index (the first) hospitalisation ranged from mean US$8340 up to US$11,366 per admission and increased up to US$31,493 for those with comorbidities. Two studies reported 1-year costs, and these were US$27,174 and US$26,343, respectively. Hospitalisation accounts for approximately 80% of total costs of HFpEF treatment. The results of this systematic review reveal that published costs of HFpEF hospitalisation are limited to nine studies from a comprehensive database search. The costs of an initial HF hospitalisation are significant, and these costs increase when a person with HFpEF presents with comorbidities or other complications.</p>en
dc.languageenen
dc.publisherSpringer New York LLCen
dc.relation.ispartofHeart Failure Reviewsen
dc.titleHospitalisation costs associated with heart failure with preserved ejection fraction (HFpEF): a systematic reviewen
dc.typeJournal Articleen
dc.identifier.doi10.1007/s10741-021-10097-7en
dc.identifier.pmid33765251en
local.contributor.firstnameHannahen
local.contributor.firstnameRezwanulen
local.contributor.firstnameJeffen
local.contributor.firstnameMelissaen
local.contributor.firstnameTomen
local.contributor.firstnameNeilen
local.profile.schoolSchool of Science and Technologyen
local.profile.schoolSchool of Science and Technologyen
local.profile.schoolSchool of Science and Technologyen
local.profile.schoolSchool of Science and Technologyen
local.profile.emailhclark22@une.edu.auen
local.profile.emailmpears28@une.edu.auen
local.profile.emailtvandert@une.edu.auen
local.profile.emailnsmart2@une.edu.auen
local.output.categoryC1en
local.record.placeauen
local.record.institutionUniversity of New Englanden
local.publisher.placeUnited States of Americaen
local.format.startpage559en
local.format.endpage572en
local.identifier.scopusid85103187489en
local.peerreviewedYesen
local.identifier.volume27en
local.identifier.issue2en
local.title.subtitlea systematic reviewen
local.contributor.lastnameClarken
local.contributor.lastnameRanaen
local.contributor.lastnameGowen
local.contributor.lastnamePearsonen
local.contributor.lastnamevan der Touwen
local.contributor.lastnameSmarten
dc.identifier.staffune-id:hclark22en
dc.identifier.staffune-id:mpears28en
dc.identifier.staffune-id:tvanderten
dc.identifier.staffune-id:nsmart2en
local.profile.orcid0000-0003-2639-2615en
local.profile.orcid0000-0002-8290-6409en
local.profile.roleauthoren
local.profile.roleauthoren
local.profile.roleauthoren
local.profile.roleauthoren
local.profile.roleauthoren
local.profile.roleauthoren
local.identifier.unepublicationidune:1959.11/31891en
local.date.onlineversion2021-03-25-
dc.identifier.academiclevelAcademicen
dc.identifier.academiclevelAcademicen
dc.identifier.academiclevelAcademicen
dc.identifier.academiclevelAcademicen
dc.identifier.academiclevelAcademicen
dc.identifier.academiclevelAcademicen
local.title.maintitleHospitalisation costs associated with heart failure with preserved ejection fraction (HFpEF)en
local.output.categorydescriptionC1 Refereed Article in a Scholarly Journalen
local.search.authorClark, Hannahen
local.search.authorRana, Rezwanulen
local.search.authorGow, Jeffen
local.search.authorPearson, Melissaen
local.search.authorvan der Touw, Tomen
local.search.authorSmart, Neilen
local.uneassociationYesen
local.atsiresearchNoen
local.sensitive.culturalNoen
local.identifier.wosid000632766600001en
local.year.available2021en
local.year.published2022en
local.fileurl.closedpublishedhttps://rune.une.edu.au/web/retrieve/69cd0e5f-c29b-4192-9b6d-d26ee23a483cen
local.subject.for2020320101 Cardiology (incl. cardiovascular diseases)en
local.subject.seo2020200202 Evaluation of health outcomesen
Appears in Collections:Journal Article
School of Science and Technology
Files in This Item:
1 files
File SizeFormat 
Show simple item record

SCOPUSTM   
Citations

13
checked on Jun 8, 2024

Page view(s)

1,448
checked on Sep 24, 2023

Download(s)

2
checked on Sep 24, 2023
Google Media

Google ScholarTM

Check

Altmetric


Items in Research UNE are protected by copyright, with all rights reserved, unless otherwise indicated.